Exact Mass: 778.30699

Exact Mass Matches: 778.30699

Found 29 metabolites which its exact mass value is equals to given mass value 778.30699, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

Bis(glutathionyl)spermine disulfide

Bis(glutathionyl)spermine disulfide

C30H54N10O10S2 (778.3465624)


   

4-O-methyl erythrostominone

4-O-methyl erythrostominone

C41H46O15 (778.2836566)


   

6,2,3-tri-O-acetylmartynoside|wiedemannioside B

6,2,3-tri-O-acetylmartynoside|wiedemannioside B

C37H46O18 (778.2684016000001)


   

Trichilia substance Tr A

Trichilia substance Tr A

C39H54O16 (778.3411684)


   

O-beta-D-xylopyranosyl-(1->4)-O-<5-O-(trans-feruloyl)-alpha-L-arabinofuranosyl-(1->3)>-O-beta-D-xylopyranosyl-(1->4)-D-xylopyranose

O-beta-D-xylopyranosyl-(1->4)-O-<5-O-(trans-feruloyl)-alpha-L-arabinofuranosyl-(1->3)>-O-beta-D-xylopyranosyl-(1->4)-D-xylopyranose

C34H50O20 (778.28953)


   
   
   

amoorinin-3-O-alpha-L-rhamnopyranosyl-(1->6)-beta-D-glucopyranoside

amoorinin-3-O-alpha-L-rhamnopyranosyl-(1->6)-beta-D-glucopyranoside

C39H54O16 (778.3411684)


   

6-O-(1-hydroxy-4-oxo-cyclohexanacetyl)acteoside

6-O-(1-hydroxy-4-oxo-cyclohexanacetyl)acteoside

C37H46O18 (778.2684016000001)


   

11alpha-acetoxy-5,14,21-trihydroxy-3beta-(tri-O-acetyl-6-deoxy-alpha-L-talopyranosyloxy)-24-nor-5beta,14beta-chol-20(22)t-ene-19,23-dioic acid-19-ethyl ester-23=>21-lactone|11alpha-Acetoxy-5,14,21-trihydroxy-3beta-(tri-O-acetyl-6-desoxy-alpha-L-talopyranosyloxy)-24-nor-5beta,14beta-chol-20(22)t-en-19,23-disaeure-19-aethylester-23=>21-lacton

11alpha-acetoxy-5,14,21-trihydroxy-3beta-(tri-O-acetyl-6-deoxy-alpha-L-talopyranosyloxy)-24-nor-5beta,14beta-chol-20(22)t-ene-19,23-dioic acid-19-ethyl ester-23=>21-lactone|11alpha-Acetoxy-5,14,21-trihydroxy-3beta-(tri-O-acetyl-6-desoxy-alpha-L-talopyranosyloxy)-24-nor-5beta,14beta-chol-20(22)t-en-19,23-disaeure-19-aethylester-23=>21-lacton

C39H54O16 (778.3411684)


   

cantleyoside methyl hemiacetal

cantleyoside methyl hemiacetal

C34H50O20 (778.28953)


   
   

[IIN-based: Match]

NCGC00381134-01! [IIN-based: Match]

C43H54O13 (778.3564234)


   

[IIN-based on: CCMSLIB00000846922]

NCGC00381134-01! [IIN-based on: CCMSLIB00000846922]

C43H54O13 (778.3564234)


   

benzene-1,3-dicarboxylic acid,2,2-dimethylpropane-1,3-diol,ethane-1,2-diol,2-ethyl-2-(hydroxymethyl)propane-1,3-diol,hexanedioic acid,terephthalic acid

benzene-1,3-dicarboxylic acid,2,2-dimethylpropane-1,3-diol,ethane-1,2-diol,2-ethyl-2-(hydroxymethyl)propane-1,3-diol,hexanedioic acid,terephthalic acid

C35H54O19 (778.3259134)


   

Phenyl 4,6-bis-O-(phenylmethyl)-1-thio-beta-D-galactopyranoside 2-benzoate 3-(9H-fluoren-9-ylmethyl carbonate)

Phenyl 4,6-bis-O-(phenylmethyl)-1-thio-beta-D-galactopyranoside 2-benzoate 3-(9H-fluoren-9-ylmethyl carbonate)

C48H42O8S (778.2600252000001)


   

Upadacitinib hemihydrate

Upadacitinib hemihydrate

C34H40F6N12O3 (778.3250362)


D004791 - Enzyme Inhibitors > D047428 - Protein Kinase Inhibitors > D000075242 - Janus Kinase Inhibitors D018501 - Antirheumatic Agents

   
   

4-O-(8-guaiacylglycerol)buddlenol A

4-O-(8-guaiacylglycerol)buddlenol A

C41H46O15 (778.2836566)


   

GalA(-)beta1-4Glcbeta1-6(Galbeta1-4)GlcNAcbetaO[CH2]3NH3(+)

GalA(-)beta1-4Glcbeta1-6(Galbeta1-4)GlcNAcbetaO[CH2]3NH3(+)

C29H50N2O22 (778.2855079999999)


   

(2S,3R,4S,5R,6R)-6-[(2R,3S,4R,5R,6R)-6-[[(2R,3S,4R,5R,6R)-5-acetamido-6-(3-aminopropoxy)-4-hydroxy-3-[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]methoxy]-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid

(2S,3R,4S,5R,6R)-6-[(2R,3S,4R,5R,6R)-6-[[(2R,3S,4R,5R,6R)-5-acetamido-6-(3-aminopropoxy)-4-hydroxy-3-[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]methoxy]-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid

C29H50N2O22 (778.2855079999999)


   

[(1S,2R,4S,5R,6S,7S,8R,9R,12R)-7,12-diacetyloxy-6-(acetyloxymethyl)-5-benzoyloxy-2,10,10-trimethyl-4-octanoyloxy-11-oxatricyclo[7.2.1.01,6]dodecan-8-yl] benzoate

[(1S,2R,4S,5R,6S,7S,8R,9R,12R)-7,12-diacetyloxy-6-(acetyloxymethyl)-5-benzoyloxy-2,10,10-trimethyl-4-octanoyloxy-11-oxatricyclo[7.2.1.01,6]dodecan-8-yl] benzoate

C43H54O13 (778.3564234)


   
   
   
   

Angiotensin I/II (1-5) (TFA)

Angiotensin I/II (1-5) (TFA)

C32H49F3N8O11 (778.3472720000001)


Angiotensin I/II 1-5 TFA is a peptide that contains the amino acids 1-5, which is converted from Angiotensin I/II. Angiotensin I is formed by the action of renin on angiotensinogen. Angiotensin II is produced from angiotensin I. Angiotensin I/II 1-5 TFA is an active mediator of renin-angiotensin system to stimulate atrial natriuretic peptide (ANP) secretion via Mas R and PI3K-Akt-NOS pathway.[1][2].

   

Angiotensin I/II (1-5) (TFA)

Angiotensin I/II (1-5) (TFA)

C32H49F3N8O11 (778.3472720000001)


Angiotensin I/II 1-5 TFA is a peptide that contains the amino acids 1-5, which is converted from Angiotensin I/II. Angiotensin I is formed by the action of renin on angiotensinogen. Angiotensin II is produced from angiotensin I. Angiotensin I/II 1-5 TFA is an active mediator of renin-angiotensin system to stimulate atrial natriuretic peptide (ANP) secretion via Mas R and PI3K-Akt-NOS pathway.[1][2].